Press releases

Media contact: Stéphanie Bardon – communication@genethon.fr – 01.69.47.12.78

Genethon to Showcase the Latest Advances in Gene Therapies for Multiple Diseases at the ESGCT 31st Annual Congress October 22 – 25, 2024 in Rome, Italy

(read more)

Genethon and Samabriva strengthen their partnership to develop of a cost-effective plant-based AAV manufacturing process for greater patient access to gene therapies.

(read more)

Genethon Announces Publication in Nature Communications of a Next-Generation Gene Therapy Vector for Muscle Diseases, Using AI Predictive Methodology to Improve Efficacy and Safety

(read more)

Marking World Duchenne Muscular Dystrophy Day, Genethon Reaffirms Its Commitment to Helping Patientsfor 35 years and Provides an Update on Its PromisingGene Therapy Drug Candidate for This Fatal Disease

(read more)

Genethon’s Scientists Featured in Multiple Presentations at American Society of Gene & Cell Therapy Annual Meeting May 7-11, 2024, in Baltimore, MD

(read more)

GenoTher, biocluster in the field of gene therapy is officially launched

(read more)

First Clinical Trial Results of Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy presented at International Myology 2024 Congress

(read more)

Genethon will introduce its latest advances in gene therapy research in multiple presentations at the International Myology 2024 Congress

(read more)

Genethon Pursues Different Strategies for Ensuring Patient Access to Gene Therapies for Rare Diseases

(read more)

Clinical results of the gene therapy trial in myotubular myopathy : efficacy on respiratory and motor functions in this extremely severe disease, challenges ahead

(read more)

The Latest Research of 14 Généthon Scientists to be Featured at the European Society of Gene & Cell Therapy’s 30th Annual Congress, Oct. 24-27, 2023, in Brussels, Belgium

(read more)

First results of Crigler-Najjar clinical trial published in New England Journal of Medicine

(read more)

Genethon and Thales collaborate on artificial intelligence to improve bioproduction efficiency

(read more)

Upholder of excellence in gene therapyGenother awarded Biocluster label

(read more)

Genethon’s R&D to be Featured in Multiple Presentations at American Society of Gene & Cell Therapy Annual Meeting May 16-20, 2023, in Los Angeles, CA

(read more)